Ilumya Injection and Insulin Glargine (U-300) Pens
Determining the interaction of Ilumya Injection and Insulin Glargine (U-300) Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: tildrakizumab
Brand name: Ilumya
Synonyms: Ilumya
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ilumya Injection-Insulin glargine and lixisenatide
- Ilumya Injection-Insulin glargine and lixisenatide Subcutaneous
- Ilumya Injection-Insulin glargine, recombinant Subcutaneous
- Ilumya Injection-Insulin glulisine
- Ilumya Injection-Insulin Glulisine (Cartridges and Pens)
- Ilumya Injection-Insulin Glulisine (Vials)
- Insulin Glargine (U-300) Pens-Iluvien
- Insulin Glargine (U-300) Pens-Iluvien Implant
- Insulin Glargine (U-300) Pens-Imatinib
- Insulin Glargine (U-300) Pens-Imatinib Mesylate
- Insulin Glargine (U-300) Pens-Imbruvica
- Insulin Glargine (U-300) Pens-Imbruvica (Ibrutinib Capsules)